Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human LGALS9 Protein, N-His

Catalog #:   YHA04301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O00182
Protein length: Met1-Gln148
Overview

Catalog No.

YHA04301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Gln148

Predicted molecular weight

18.66 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O00182

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Ecalectin, LGALS9, Galectin-9, Gal-9, Tumor antigen HOM-HD-21

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human LGALS9 protein
References

Role of galectin-9 in the development of gestational diabetes mellitus., PMID:40447728

IFN-α and vitamin B6-induced galectin-9 promotes the immunomodulatory function of human clonal mesenchymal stem cells., PMID:40442825

Endometrial Stromal Senescence Mediates the Progression of Intrauterine Adhesions., PMID:40362421

Integrative Analysis Reveals Genes Causal Relation with Ovarian Cancer and aging., PMID:40353459

Autophagy-independent role of ATG9A vesicles as carriers for galectin-9 secretion., PMID:40335523

The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk., PMID:40301994

An In-Silico Study to Identify Relevant Biomarkers in Sepsis Applying Integrated Bulk RNA Sequencing and Single-Cell RNA Sequencing Analyses., PMID:40255236

Candidalysin induces Tim-3 expression in macrophages to suppress antifungal immunity in oropharyngeal candidiasis., PMID:40252466

Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy., PMID:40196117

Expression Patterns of Immune Checkpoint Molecules and Their Clinical Values in Gastric Neuroendocrine Neoplasms., PMID:40183457

New insights on Galectin-9 expression in cancer prognosis: An updated systemic review and meta-analysis., PMID:40138336

Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis., PMID:40114078

Differential expression of endothelial derived galectins in response to shear stress., PMID:40107440

Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia., PMID:40106574

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia., PMID:40090006

Expression of co-signaling molecules TIM-3/Galectin-9 at the maternal-fetal interface., PMID:40068377

Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment., PMID:39983894

Synthetic and plant-derived multivalent galactans as modulators of cancer-associated galectins-3 and -9., PMID:39971027

It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma., PMID:39958335

Dichotomous effects of Galectin-9 in disease modulation in murine models of inflammatory bowel disease., PMID:39951917

Bioinformatics Analysis of Key Genes Associated with Resistance to the Combination of Bevacizumab and Pemetrexed Chemotherapy in Non-small Cell Lung Cancer., PMID:39945271

Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activation., PMID:39910335

Plasma proteomics for risk prediction and identification of novel drug targets in systemic lupus erythematosus., PMID:39883569

Single-cell RNA sequencing revealed the immunophenotypic features of macrophages in cardiac transplants and uncovered Lgals9 promoted their polarization toward the M2b subtype., PMID:39835675

Dynamic analysis of intrahepatic T cells reveals a unique group of restorative Cxcr3+ tissue-resident CD4 T cells in acute liver injury., PMID:39828240

Identification of Drug-Targetable Genes for Eczema and Dermatitis Using Integrated Genomic and Proteomic Approaches., PMID:39786806

Uncovering NK cell sabotage in gut diseases via single cell transcriptomics., PMID:39752457

Galectin 9 rescues the inducibility of IL-10 expression in regulatory B cells of patients with food allergy., PMID:39747510

Serum Galectin-9 mirrors immune-evasive microenvironment and predicts early recurrence in hepatocellular carcinoma., PMID:39706231

Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma., PMID:39670859

Prediction of Major Adverse Limb Events in Females with Peripheral Artery Disease using Blood-Based Biomarkers and Clinical Features., PMID:39643751

LGALS9B stabilizes EEF1D protein and activates the PI3K/AKT signaling pathway to promote gastric cancer occurrence and metastasis., PMID:39639171

Immunomodulation by galectin-9: Distinct role in T cell populations, current therapeutic avenues and future potential., PMID:39571310

Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domain., PMID:39549501

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia., PMID:39505795

Plasma High-Mobility Group Box-1 and Galectin-9 in Patients with Trauma and Their Prognostic Potentials., PMID:39505526

CD137 Protein Expression Pattern Determines the Functional Role of Galectin-9 in Colorectal Cancer., PMID:39503215

Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth., PMID:39495223

Microglia-derived Galectin-9 drives amyloid-β pathology in Alzheimer's disease., PMID:39485716

Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma., PMID:39481387

TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal Adenocarcinoma., PMID:39457004

Monocyte-derived Galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy., PMID:39445017

MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma., PMID:39424990

Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function., PMID:39386210

Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma., PMID:39386209

A study of the association of vitamin D receptor (VDR) as a predictive biomarker for immune checkpoint inhibitor therapy with immune invasion in colon adenocarcinoma., PMID:39378759

Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma., PMID:39366979

Investigating interferon type I responses in patients with suspected giant cell arteritis and polymyalgia rheumatica., PMID:39364727

Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients., PMID:39334929

Galectin-9 as a new biomarker of acute-on-chronic liver failure., PMID:39333198

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human LGALS9 Protein, N-His [YHA04301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only